LMAT vs PAHC: fair value comparison
LeMaitre Vascular, Inc. and Phibro Animal Health Corporation · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, LMAT currently sits closer to the top of our discount ranking. LMAT carries the stronger quality grade.
| LMAT | PAHC | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $103.61 | $37.15 |
| 12-month range | $79.78–$111.76 | $29.76–$54.68 |
| Sector rank | #38 of 113 Healthcare | #42 of 113 Healthcare |
| Quality grade | C+ | D |
| Momentum grade | — | A |
| Leverage | Low | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: LMAT fair value analysis · PAHC fair value analysis